These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3664935)

  • 1. Effects of verapamil on the pharmacokinetics of daunomycin in the rat.
    Nooter K; Oostrum R; Deurloo J
    Cancer Chemother Pharmacol; 1987; 20(2):176-8. PubMed ID: 3664935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the pharmacokinetics of daunomycin in normal and leukemic rats.
    Nooter K; Sonneveld P; Martens A
    Cancer Res; 1985 Sep; 45(9):4020-5. PubMed ID: 4027999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated daunomycin administration in rats. Pharmacokinetics and bone marrow toxicity.
    Nooter K; Sonneveld P; Deurloo J; Oostrum R; Schultz F; Martens A; Hagenbeek A
    Cancer Chemother Pharmacol; 1984; 12(3):187-9. PubMed ID: 6705136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and myelotoxicity of daunomycin in the rat: rapid bolus injection vs continuous infusion.
    Nooter K; Sonneveld P; Martens A; Hagenbeek A; Schultz F
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):801-6. PubMed ID: 3770038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.
    Huwyler J; Yang J; Pardridge WM
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1541-6. PubMed ID: 9316870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daunorubicin and daunorubicinol pharmacokinetics in plasma and tissues in the rat.
    Cusack BJ; Young SP; Olson RD
    Cancer Chemother Pharmacol; 1995; 35(3):213-8. PubMed ID: 7805179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil prevents the effects of daunomycin on the thermotropic phase transition of model lipid bilayers.
    Canaves JM; Ferragut JA; Gonzalez-Ros JM
    Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):413-8. PubMed ID: 1953639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of acute anthracycline cardiotoxicity in isolated rat hearts: carminomycin versus daunomycin.
    Saman S; Jacobs P; Opie LH
    Cancer Res; 1984 Apr; 44(4):1316-20. PubMed ID: 6704950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
    Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between technetium-99m-sestamibi and hydrogen-3-daunomycin myocardial cellular retention in vitro.
    Cayre A; Moins N; Finat-Duclos F; Verrelle P; Maublant J
    J Nucl Med; 1997 Nov; 38(11):1674-7. PubMed ID: 9374331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat.
    Cusack BJ; Young SP; Vestal RE; Olson RD
    Cancer Chemother Pharmacol; 1997; 39(6):505-12. PubMed ID: 9118462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects.
    Schnyder A; Krähenbühl S; Drewe J; Huwyler J
    J Drug Target; 2005 Jun; 13(5):325-35. PubMed ID: 16199376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of verapamil on daunomycin cellular retention and cytotoxicity in P388 leukemic cells.
    Yanovich S; Preston L
    Cancer Res; 1984 May; 44(5):1743-7. PubMed ID: 6713377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipid metabolism in daunomycin-induced nephrotic rats (Part 6)].
    Gomikawa S; Inagaki O; Mori H; Inoue S; Takamitsu Y; Fujita Y
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):239-46. PubMed ID: 8501853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
    Satyamoorthy K; Perchellet JP
    Cancer Res; 1989 Oct; 49(19):5364-70. PubMed ID: 2475247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of MDR reversing agent combinations on the 3H-daunomycin accumulation in drug-sensitive and drug-resistant human cancer cells.
    Moins N; Cayre A; Chevillard S; Maublant J; Verrelle P; Finat-Duclos F
    Anticancer Res; 2000; 20(4):2617-23. PubMed ID: 10953334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multidrug transporter: rapid modulation of efflux activity monitored in single cells by the morphologic effects of vinblastine and daunomycin.
    Konen PL; Currier SJ; Rutherford AV; Gottesman MM; Pastan I; Willingham MC
    J Histochem Cytochem; 1989 Jul; 37(7):1141-5. PubMed ID: 2567301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daunomycin secretion by killfish renal proximal tubules.
    Miller DS
    Am J Physiol; 1995 Aug; 269(2 Pt 2):R370-9. PubMed ID: 7653659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents.
    Cayre A; Moins N; Finat-Duclos F; Maublant J; Verrelle P
    J Nucl Med; 1999 Apr; 40(4):672-6. PubMed ID: 10210228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of P-glycoprotein-mediated daunomycin transport in rat liver canalicular membrane vesicles.
    Kwon Y; Kamath AV; Morris ME
    J Pharm Sci; 1996 Sep; 85(9):935-9. PubMed ID: 8877882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.